Misdiagnosis can lead to inappropriate treatment with anti-inflammatory drugs such as corticosteroids, that are ineffective in treating the consequences of dysferlin mutations and typically result in many adverse side effects, including loss of muscle strength, reduced bone density, hypertension, cataracts, and diabetes [56]. The gene discussed is DYSF; the disease is cataract.